1-13 of 13
Razelle Kurzrock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab

Open Access
Ashkan Adibi, Ünal Metin Tokat, Esranur Aydın, Eylül Özgü, Şevval Nur Bilgiç ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2025) 8 (2): 184–190.
https://doi.org/10.36401/JIPO-25-3
Published: 12 May 2025
View articletitled, Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab
Open the PDF for Exceptional Response in a Patient with mRCC Through Precision-Guided Treatment Involving Immunotherapy Rechallenge with Temsirolimus and Bevacizumab in another window
Includes: Supplementary data
Journal Articles

Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases

Open Access
Bicky Thapa, Aditya Shreenivas, Kathryn Bylow, Hui-Zi Chen, Ben George ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (4): 308–313.
https://doi.org/10.36401/JIPO-24-13
Published: 01 November 2024
View articletitled, Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases
Open the PDF for Successful Targeting of Somatic VHL Alterations With Belzutifan in Two Cases in another window
Journal Articles

How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience

Open Access
Razelle Kurzrock, David Hong
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (3): 142–149.
https://doi.org/10.36401/JIPO-23-243
Published: 19 August 2024
View articletitled, How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience
Open the PDF for How to Build a Successful Phase I Clinical Trials Unit: Lessons Based on the MD Anderson Cancer Center Experience in another window
Journal Articles

Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma

Open Access
Anagha Deshpande, Javier Munoz, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (3): 201–204.
https://doi.org/10.36401/JIPO-23-47
Published: 19 August 2024
View articletitled, Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma
Open the PDF for Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma in another window
Journal Articles

Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1

Open Access
Anagha Deshpande, Javier Munoz, Vrushali Dabak, Amr Hanbali, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2024) 7 (2): 122–125.
https://doi.org/10.36401/JIPO-23-32
Published: 02 May 2024
View articletitled, Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1
Open the PDF for Images in Immunotherapy and Precision Oncology: A Case Report of Neurofibromatosis-1 in another window
Journal Articles

Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse

Open Access
Andrea Castro, Aaron M. Goodman, Zachary Rane, James V. Talwar, Garrett M. Frampton ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2023) 6 (3): 127–132.
https://doi.org/10.36401/JIPO-22-19
Published: 15 May 2023
View articletitled, Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse
Open the PDF for Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse in another window
Includes: Supplementary data
Journal Articles

Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver

Open Access
Anagha Deshpande, Javier Munoz, Katalin Kelemen, Vrushali Dabak, Amr Hanbali ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2022) 6 (1): 56–58.
https://doi.org/10.36401/JIPO-22-22
Published: 27 December 2022
View articletitled, Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver
Open the PDF for Images in Immunotherapy and Precision Oncology: Angiosarcoma of the Spleen and Liver in another window
Journal Articles

Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken

Open Access
Mina Nikanjam, Shumei Kato, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2022) 5 (4): 87–89.
https://doi.org/10.36401/JIPO-22-X3
Published: 06 October 2022
View articletitled, Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken
Open the PDF for Of Mice, Not Men: When the Bench-to-Bedside Bridge Is Broken in another window
Journal Articles

Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy

Open Access
Nicholas J. Bevins, Ryosuke Okamura, Meagan Montesion, Jacob J. Adashek, Aaron M. Goodman ...
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2022) 5 (4): 90–97.
https://doi.org/10.36401/JIPO-22-9
Published: 22 September 2022
View articletitled, Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
Open the PDF for Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy in another window
Includes: Supplementary data
Journal Articles

The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers

Open Access
Diviya Gupta, Shumei Kato, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2020) 4 (2): 56–63.
https://doi.org/10.36401/JIPO-20-30
Published: 13 November 2020
View articletitled, The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers
Open the PDF for The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers in another window
Journal Articles

Repurposing Interleukin-6 Inhibitors to Combat COVID-19

Open Access
Shumei Kato, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2020) 3 (2): 52–55.
https://doi.org/10.36401/JIPO-20-11
Published: 22 May 2020
View articletitled, Repurposing Interleukin-6 Inhibitors to Combat COVID-19
Open the PDF for Repurposing Interleukin-6 Inhibitors to Combat COVID-19 in another window
Journal Articles

Are Cancer Patients at Higher Risk of Death with COVID-19?

Open Access
Jacob J. Adashek, Joud Hajjar, Roy F. Chemaly, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2020) 3 (2): 49–51.
https://doi.org/10.4103/2666-2345.280883
Published: 17 March 2020
View articletitled, Are Cancer Patients at Higher Risk of Death with COVID-19?
Open the PDF for Are Cancer Patients at Higher Risk of Death with COVID-19? in another window
Journal Articles

In the Era of Immune Checkpoint Inhibitor Therapy, Can We Safely Expand to Patients with Immunodeficiency?

Open Access
Mehmet Asim Bilen, Razelle Kurzrock
Journal: Journal of Immunotherapy and Precision Oncology
Journal of Immunotherapy and Precision Oncology (2019) 2 (4): 129.
https://doi.org/10.4103/JIPO.JIPO_20_19
Published: 18 October 2019
View articletitled, In the Era of Immune Checkpoint Inhibitor Therapy, Can We Safely Expand to Patients with Immunodeficiency?
Open the PDF for In the Era of Immune Checkpoint Inhibitor Therapy, Can We Safely Expand to Patients with Immunodeficiency? in another window